相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
Namdev S. Togre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements
Ildar R. Iusupov et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
Gregory T. Robertson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Species-Specific Urothelial Toxicity With an Anti-HIV Noncatalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes
Ruth A. Roberts et al.
TOXICOLOGICAL SCIENCES (2021)
Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
Jennifer A. Borthwick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fragment-based approaches to TB drugs
Chiara Marchetti et al.
PARASITOLOGY (2018)
'Tethering' fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase
Adam Heikal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from &ITMycobacterium tuberculosis&IT
Ana Trapero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
Rupesh V. Chikhale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Guanidine-Containing Phenyl-Pyrrole Compounds as Probes for Generating HIV Entry Inhibitors Targeted to gp120
Dmitry S. Belov et al.
CHEMISTRYSELECT (2018)
Using Fragment-Based Approaches to Discover New Antibiotics
Bas Lamoree et al.
SLAS DISCOVERY (2018)
Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis
Sangeeta Tiwari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors
Maciej K. Rogacki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-beta-D-ribose 2 '-Oxidase
Sangmi Oh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Protein-Templated Fragment Ligations-From Molecular Recognition to Drug Discovery
Mike Jaegle et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
Petar O. Nikiforov et al.
ACS CHEMICAL BIOLOGY (2017)
Targeting tuberculosis using structure-guided fragment-based drug design
Vitor Mendes et al.
DRUG DISCOVERY TODAY (2017)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
Petar O. Nikiforov et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2′-oxidase
Sudhir Landge et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor
Francesca Curreli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
Francesca Curreli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis
Michael Berney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening
Jennifer La et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
Joao Neres et al.
ACS CHEMICAL BIOLOGY (2015)
Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study
Francesca Curreli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Craig Fenwick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
Monalisa Chatterji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Inhibition of Mycobacterium tuberculosis Transaminase BioA by Aryl Hydrazines and Hydrazides
Ran Dai et al.
CHEMBIOCHEM (2014)
Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease
Theresa Tiefenbrunn et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches
Baptiste Villemagne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
Maruti Naik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
Manoranjan Panda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants
Gaelle S. Kolly et al.
MOLECULAR MICROBIOLOGY (2014)
Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site
Young Do Kwon et al.
PLOS ONE (2014)
Towards novel therapeutics for HIV through fragment-based screening and drug design
Theresa Tiefenbrunn et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2014)
The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Nicolas Sluis-Cremer
VIRUSES-BASEL (2014)
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Lee D. Fader et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Entry inhibitors and their use in the treatment of HIV-1 infection
Aiman A. Haqqani et al.
ANTIVIRAL RESEARCH (2013)
Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents
Chao Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Allosteric inhibition of HIV-1 integrase activity
Alan Engelman et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors
Kellie Ann Jurado et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2013)
Thiolactomycin-based β-Ketoacyl-AcpM Synthase A (KasA) Inhibitors FRAGMENT-BASED INHIBITOR DISCOVERY USING TRANSIENT ONE-DIMENSIONAL NUCLEAR OVERHAUSER EFFECT NMR SPECTROSCOPY
Kanishk Kapilashrami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Homology Model of HIV-1 Integrase and Analysis of Mutations Designed to Test the Model
Barry C. Johnson et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Correction: Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design
Thomas S. Peat et al.
PLoS One (2013)
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
Sarah A. Stanley et al.
ACS CHEMICAL BIOLOGY (2012)
Elucidation of Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors using a Fragment Elaboration Strategy
Anh Thu Tran et al.
CHEMMEDCHEM (2012)
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis
Marion Flipo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design and Synthesis of Potential Mechanism-Based Inhibitors of the Aminotransferase BioA Involved in Biotin Biosynthesis
Ce Shi et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
The structural biology of HIV-1: mechanistic and therapeutic insights
Alan Engelman et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
Sarah M. Batt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identifying Vulnerable Pathways in Mycobacterium tuberculosis by Using a Knockdown Approach
Paul Carroll et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1
Jerome Wielens et al.
CHEMMEDCHEM (2011)
Identification of a Novel Scaffold for Allosteric Inhibition of Wild Type and Drug Resistant HIV-1 Reverse Transcriptase by Fragment Library Screening
Matthis Geitmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Small-Molecule Probe Induces a Conformation in HIV TAR RNA Capable of Binding Drug-Like Fragments
Amy Davidson et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
FRET analysis reveals distinct conformations of IN tetramers in the presence of viral DNA or LEDGF/p75
Jacques J. Kessl et al.
NUCLEIC ACIDS RESEARCH (2011)
Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
Paul K. Crellin et al.
PLOS ONE (2011)
Screening for GPCR Ligands Using Surface Plasmon Resonance
Iva Navratilova et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression
Sae Woong Park et al.
PLOS PATHOGENS (2011)
Exploring Drug Target Flexibility Using in Situ Click Chemistry: Application to a Mycobacterial Transcriptional Regulator
Nicolas Willand et al.
ACS CHEMICAL BIOLOGY (2010)
HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
Neel R. Gandhi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Annemarie M. J. Wensing et al.
ANTIVIRAL RESEARCH (2010)
Fragment-Based Screen against HIV Protease
Alexander L. Perryman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Decaprenylphosphoryl-beta-D-Ribose 2 '-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
G. Manina et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site
Jerome Wielens et al.
FEBS LETTERS (2010)
Impact of HIV Infection on the Recurrence of Tuberculosis in South India
Sujatha Narayanan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design
Eric B. Lansdon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel Small Molecule Inhibitors of MDR Mycobacterium tuberculosis by NMR Fragment Screening of Antigen 85C
Christoph Scheich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
New molecular scaffolds for the design of Mycobacterium tuberculosis type II dehydroquinase inhibitors identified using ligand and receptor based virtual screening
Ashutosh Kumar et al.
JOURNAL OF MOLECULAR MODELING (2010)
Structure-based modeling of the functional HIV-1 intasome and its inhibition
Lavanya Krishnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular Basis for Drug Resistance in HIV-1 Protease
Akbar Ali et al.
VIRUSES-BASEL (2010)
Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
Stefan G. Sarafianos et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Nicolas Willand et al.
NATURE MEDICINE (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: Insight into integrase-DNA complex formation and catalysis
Laith Q. Al-Mawsawi et al.
FEBS LETTERS (2008)
Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein
Christopher J. McKee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Lin Shen et al.
NATURE MEDICINE (2008)
Mechanism of thioamide drug action against tuberculosis and leprosy
Feng Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended
Ofir Korazim et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
J Wang et al.
NATURE (2006)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Q Zhao et al.
VIROLOGY (2005)
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs
AL Perryman et al.
PROTEIN SCIENCE (2004)
Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase
P Cherepanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion
K Sackett et al.
BIOCHEMISTRY (2002)
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
P Sonnenberg et al.
LANCET (2001)
Inhibition of β-ketoacyl-acyl carrier protein syntheses by thiolactomycin and cerulenin -: Structure and mechanism
AC Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutants of Mycobacterium smegmatis impaired in stationary-phase survival
J Keer et al.
MICROBIOLOGY-SGM (2000)
分享论文
